MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-33-0058548
Celagenex Research (India) Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹156.68 Cr
▲ 53% YoY
Net loss · FY 2025
₹9.12 Cr
Net margin -5.8%
EBITDA · FY 2025
-₹6.09 Cr
EBITDA margin -3.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.77 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
687
Provident fund records
Directors on board
2
As per MCA filings
About Celagenex Research (India) Private Limited
Data last updated:
Celagenex Research (India) Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36997MH2019PTC331430. Its GSTIN is 27AAICC4124A1Z7 (Maharashtra). The company holds 10 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.77 Lakh. It is led by directors Dilip Gopal Nevrekar and Rajaram Shriram Samant.
Its last annual general meeting (AGM) was held on 18 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹156.68 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net loss of ₹9.12 Cr (net margin -5.8%) and EBITDA of -₹6.09 Cr (EBITDA margin -3.9%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years and 199% over five years.
The company has about 687 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Celagenex. Court records list 13 cases involving the company, including 12 filed by the company and 1 filed against it; 10 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2022.
Celagenex Research (India) Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0058548). For more details, the company can be reached via its website celagenex.com.
Company details
CIN U36997MH2019PTC331430
Registration Number 331430
Incorporation Date 09 October 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0058548
Recognitions & Rankings of Celagenex Research (India)
Contact details
Celagenex Research (India) Private Limited's registered office is in Thane, Maharashtra. Its website is celagenex.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address6th Floor Bellona Building, Behind The Walk Hiranandani Estate Kolshet Village, Thane, Maharashtra, India – 400607
- IndustryPharma, Pharmaceutical Retailers & Distributors, Pharma Contract R&D
To see the full contact details of Celagenex Research (India) Private Limited, buy the company report.
Comprehensive company report
Celagenex Research (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Celagenex Research (India) operates one associated brand: Celagenex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops innovative treatments for diabetes, neurological disorders, and chronic health issues. | celagenex.com |
Business activity
The main business activity of Celagenex Research (India) is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of Celagenex Research (India) Private Limited, buy the company report.
Financials of Celagenex Research (India) Private Limited
FY 2025 filings availableCelagenex Research (India) Private Limited reported revenue of ₹156.68 Cr (up 53% YoY) for FY 2025.
Revenue · FY 2025
₹156.68 Cr ▲ 53%
Net loss · FY 2025
₹9.12 Cr margin -5.8%
EBITDA · FY 2025
-₹6.09 Cr margin -3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 53%
3 years · compounded
▲ 79%
5 years · compounded
▲ 199%
EBITDA CAGR growth
1 year
▼ 138%
3 years · compounded
▼ 235%
5 years · compounded
▼ 19%
Revenue has grown at a compounded annual rate (CAGR) of 199% over five years, including 53% growth in the latest year. EBITDA fell 138% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3.9% | ||||
| Net Profit Margin | -5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Celagenex Research (India) Private Limited, buy the company report.
Board of directors of Celagenex Research (India) Private Limited
Celagenex Research (India) has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dilip Gopal Nevrekar | Director | 01 Sep 2022 | 4 Years 2 Months | Current |
| Rajaram Shriram Samant Also directs: Mplier Venture Partners LLP, K9 Health Private Limited | Director | 25 Mar 2020 | 6 Years 7 Months | Current |
Auditor
Celagenex Research (India) Private Limited is audited by Tanveer Bhagat & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Tanveer Bhagat & Co. | FY 2024 | 140696W |
Shareholding
The shareholding of Celagenex Research (India) Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Celagenex Research (India) Private Limited, buy the company report.
Deals & funding
Celagenex Research (India) Private Limited has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2022.
Total deals
3
Secondary share transfers
2
Rights issue
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2020 | Rights issue | ₹20.59 Cr | Investors: 4 individuals |
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Celagenex Research (India) Private Limited has 13 court cases on record: 12 filed by Celagenex Research (India), 1 filed against it. 10 cases are pending and 3 are disposed.
Total cases
13
Filed by the company
12
Filed against the company
1
Pending
10
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 0 | 7 |
| High courts | 5 | 1 | 2 |
| Supreme Court | 1 | 0 | 1 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed by the company against Nugenesys Pharmaceuticals Pvt. Ltd. | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed by the company against M/S. Mediworm Private Limited and 2 others | Pending |
| High Court | Court case (COMMP) | Filed by the company against Alniche Lifesciences Private Limited and 1 other | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Alniche Lifesciences Private Limited and 1 other | Pending |
| High Court of Delhi | Court case (FAO(OS) (COMM)) | Filed against the company by Nugenesys Pharmaceuticals Pvt. Ltd. and Anr, | Disposed |
To see the full case history of Celagenex Research (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celagenex Research (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Celagenex Research (India) Private Limited has a workforce of 687 employees on its EPFO records as of Mar 06, 2025, across 1 active EPFO establishment.
Employee count
687
Active EPFO establishments
1
Employee growth
68.8%
GST
Celagenex Research (India) has 10 GST registrations: 2 active and 8 cancelled or inactive.
Total GSTINs
10
Active
2
Cancelled / inactive
8
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICC4124A1Z7 | Maharashtra | Active | 05 Dec 2019 |
| 24AAICC4124A1ZD | Gujarat | Active | 01 Jul 2021 |
To see the full GST registrations and return filing status of Celagenex Research (India) Private Limited, buy the company report.
Recent activity
Celagenex Research (India) Private Limited has 7 board changes on record since 2020: 2 appointments and 5 cessations. The latest: Shoyeb Abdul Gafoor Mandlekar ceased to be Director on 09 Oct 2024.
AGM
Celagenex Research (India) Private Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records.
Filing
Celagenex Research (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Shoyeb Abdul Gafoor Mandlekar ceased to be Director.
Ceased
Dilip Gopal Nevrekar ceased to be Additional Director.
Appointed
Dilip Gopal Nevrekar was appointed as Director.
Ceased
Rajaram Shriram Samant ceased to be Additional Director.
Ceased
Ujwala Rajaram Samant ceased to be Additional Director.
Appointed
Rajaram Shriram Samant was appointed as Director.
Ceased
Sarah Akram Kazi ceased to be Director.
Incorporation
09 Oct 2019
Celagenex Research (India) Private Limited was registered on 09 Oct 2019 with Roc Mumbai & aged 7 years 30 days as per MCA records.
Frequently asked questions
Celagenex Research (India) is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 October 2019 (7+ years old) and is registered under CIN U36997MH2019PTC331430.
Celagenex Research (India) has 2 current directors:
- Dilip Gopal Nevrekar - Director
- Rajaram Shriram Samant - Director
The latest financial statements of Celagenex Research (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 18 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Celagenex Research (India) is 27AAICC4124A1Z7, registered in Maharashtra. The company has 10 GST registrations in all, of which 2 are active and 8 are cancelled or inactive. Other active GSTINs include 24AAICC4124A1ZD (Gujarat).
The CIN (Corporate Identification Number) of Celagenex Research (India) is U36997MH2019PTC331430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celagenex Research (India) has 13 court cases on record: 12 filed by the company and 1 filed against it. 10 are pending. Most are in the district courts.
Celagenex Research (India) was incorporated on 09 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Celagenex Research (India) has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2022.
Shoyeb Abdul Gafoor Mandlekar ceased to be Director on 09 Oct 2024. Dilip Gopal Nevrekar ceased to be Additional Director on 13 Jul 2023. Dilip Gopal Nevrekar was appointed as Director on 01 Sep 2022. Celagenex Research (India) has 7 board changes on record in total.
Yes, Celagenex Research (India) is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0058548).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages